A 6-year-old child from rural India presents with acute bloody diarrhea, fever, and abdominal cramps for 3 days. Stool culture grows Shigella flexneri. What is the drug of choice for treatment?

Explanation

## Drug of Choice for Shigella Infection **Key Point:** Ciprofloxacin (a fluoroquinolone) is the first-line treatment for Shigella infections in children and adults, particularly in endemic regions with high resistance rates to older agents. ### Rationale for Ciprofloxacin 1. **Excellent intracellular penetration** — Shigella is an intracellular pathogen; fluoroquinolones achieve high concentrations within epithelial cells and macrophages. 2. **Broad spectrum coverage** — Effective against both susceptible and many resistant strains of Shigella. 3. **Rapid clinical response** — Reduces duration of diarrhea and bacterial shedding. 4. **Oral bioavailability** — Can be given orally in mild-to-moderate disease; IV formulation available for severe cases. ### Resistance Patterns in Shigella | Agent | Resistance Status | Notes | |-------|-------------------|-------| | Ampicillin | High (>60% in India) | No longer recommended as monotherapy | | TMP-SMX | High (>50% in India) | Resistance widespread; not reliable | | Ceftriaxone | Low-moderate | Useful alternative, but fluoroquinolone preferred | | Ciprofloxacin | Low (<10%) | Current first-line choice | **High-Yield:** In India and other endemic areas, ampicillin and TMP-SMX resistance in Shigella is extremely common due to plasmid-mediated resistance genes. Fluoroquinolones remain the most reliable empiric choice. ### Dosing in Children - **Ciprofloxacin:** 10–15 mg/kg/day in 2 divided doses for 3–5 days (oral or IV). - Duration is typically shorter (3–5 days) compared to other enteropathogens because fluoroquinolones rapidly clear the organism. **Clinical Pearl:** Although fluoroquinolones are traditionally avoided in pediatric patients due to concerns about cartilage toxicity, their use in acute bacterial diarrhea (especially Shigella) is justified because the benefit outweighs the risk in this acute, self-limited infection. ### Alternative Agents - **Ceftriaxone:** 50–80 mg/kg/day in 2–3 divided doses (IV/IM) — useful in severe disease or when fluoroquinolones are contraindicated. - **Azithromycin:** 10 mg/kg/day for 3 days — emerging option in some regions with fluoroquinolone resistance. **Warning:** Do not use ampicillin or TMP-SMX empirically in endemic regions without susceptibility testing, as resistance is predictable.